• Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia?

  • 2022/08/18
  • 再生時間: 22 分
  • ポッドキャスト

Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia?

  • サマリー

  • Modern Pathology have recently launched a new series of reviews addressing controversial issues in pathology. In this episode of ModPath CHAT, Dr. Elizabeth Montgomery, a world renowned expert in gastrointestinal pathology gives her point of view on the utility of ancillary testing for risk stratification of Barrett’s esophagus and dysplasia. 

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Modern Pathology have recently launched a new series of reviews addressing controversial issues in pathology. In this episode of ModPath CHAT, Dr. Elizabeth Montgomery, a world renowned expert in gastrointestinal pathology gives her point of view on the utility of ancillary testing for risk stratification of Barrett’s esophagus and dysplasia. 

Hosted on Acast. See acast.com/privacy for more information.

Are ancillary studies of any utility in risk assessment of Barrett’s esophagus and dysplasia?に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。